Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Laurans L, Venteclef N, Haddad Y, et al
NAD+ is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use
Contraindicated in patients with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia Syndromes (MEN 2) Consult your healthcare provider if you have a history of pancreatitis, as the medication may increase risk Serious side effects may involve hypoglycemia, kidney issues, or allergic reactions 1,5 Not suitable for individuals with type 1 diabetes or diabetic ketoacidosis Medication interactions may occur with those on insulin, oral diabetes medications, oral contraceptives, and blood thinners
133 ParikhR
02033-5/asset/e4c9417f-3cd1-4983-b1a9-6c6b1c8112ee/main.assets/gr2_lrg.jpg)
US$ 21.62
US$ 22.38
US$ 20.04
